Established in 1907, Jakemans prides itself as one of the most popular mentholated lozenge brands[1].
Naturally infused with menthol, an ingredient that releases natural vapours to ease the symptoms of a sore throat to keep airways clear, Jakemans has been soothing sore throats and coughs for over 100 years.
Using only the finest natural ingredients, Jakemans contain no artificial colours or flavours and are suitable for vegetarians.
In January 2023, Jakemans will be launching a new sugar free variant of the much-loved classic flavour, Throat & Chest in a 50g bag format.
Jakemans uses only the finest natural ingredients, contain no artificial colours or flavours and are suitable for vegetarians.
Each tasty lozenge is bursting with menthol – an ingredient that releases natural vapours to soothe the symptoms of a sore or tickly throat and keep airways clear.
Consumers will be able to purchase the sugar free option from pharmacies across the UK with an RRP of £1.29 (20 x 2.5g lozenges).
Elizabeth Hughes-Gapper, Brand Manager for Jakemans said: “It’s important we offer our customers a variety of flavours and formats and we are absolutely thrilled to be launching our most loved flavour Throat & Chest in sugar free.”
The medicated confectionery category is up by 73.8% in terms of value sales and 50.2% in terms of unit sales within the last 12 months[2].
As part of that, Jakemans has seen one of the biggest share gains in value versus two years ago[3].
Jakemans SKUs dominated the top selling bag lines and drove an impressive 89% of real value growth in bag formats within the last 12 months[4].
The ongoing success in the category can be attributed to Jakemans’ 100+ year heritage of the brand.
References:
[1] IRI Medicated Confectionery, Total Market, 52 w/e 14 May 2022
[2] IRI Medicated Confectionery, Value and Unit Sales, 52 w/e 14 May 2022, Total Market
[3] IRI Medicated Confectionery, Value Growth, 52 w/e 14 May 2022, Total Market
[4] IRI Medicated Confectionery, Value Growth, 52 w/e 14 May 2022, Total Market
